Hepaglide 1.7mg Prefilled Pen 6.8 Mg/3 Ml

Hepaglide 1.7mg Prefilled Pen 6.8 mg/3 ml is an advanced injectable therapy designed for the management of type 2 diabetes and weight control. It contains Semaglutide, a highly effective GLP-1 receptor agonist that helps regulate blood glucose levels and reduce appetite. This medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, resulting in improved glycemic control and reduced food intake.

The prefilled pen offers a precise and convenient dosing system, making it suitable for once-weekly administration. Hepaglide 1.7mg is often prescribed as part of a step-up dosing regimen to achieve optimal therapeutic outcomes. It is especially beneficial for patients who require better blood sugar control along with weight reduction support.

With its long-acting formulation, Hepaglide helps significantly lower HbA1c levels and supports sustained weight loss. It also reduces the risk of diabetes-related complications when used consistently under medical supervision. Easy to use and highly effective, Hepaglide Prefilled Pen provides a modern and reliable solution for long-term diabetes management and improved patient health.

Product Features

• Contains Semaglutide – GLP-1 receptor agonist
• Prefilled pen with 6.8mg/3ml concentration
• Once-weekly dosing for improved convenience
• Supports blood sugar control and weight management
• User-friendly injection device for easy administration

How It Helps

• Enhances insulin secretion and controls blood glucose
• Reduces appetite and promotes weight loss
• Lowers HbA1c levels effectively
• Helps prevent long-term diabetes complications